Congress is collaborating with the White House to enact a version of President Donald Trump’s Most Favored Nation drug price policy, Rep. Brett Guthrie (R-Ky.) confirmed on March 17.
“We’re still working with the White House to see where we can go,” Guthrie, chairman of the House Energy and Commerce Committee, told The Epoch Times on March 16.





